Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

XORTX Therapeutics Inc (XRTX) AI Stock Analysis

XRTX

XORTX Therapeutics Inc

(NASDAQ:XRTX)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Regulatory Pipeline ProgressThe planned Health Canada CTA and parallel U.S. strategy show that XORTX is advancing XRx-026 through defined regulatory milestones. If execution continues, the approach could accelerate clinical data generation, support future filings, and broaden access to the company’s proprietary oxypurinol formulation.
Negative Factors
No Commercial RevenueThe absence of revenue confirms that XORTX has not yet established a commercial earnings base and remains dependent on successful development and future approvals. Persistent losses limit internally generated funding and leave the company exposed to continued operating and commercialization uncertainty.

XORTX Therapeutics Inc (XRTX) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%XRTX-67.17%SPY+12.58%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.83M
Dividend Yield
―
Average Volume (3M)
723.46K
Price to Earnings (P/E)
-0.4
Beta (1Y)
0.63
Revenue Growth
―
EPS Growth
-1.91%
Country
US
Employees
2
Sector
General
Sector Strength
55
Industry
Biotechnology

XORTX Therapeutics Inc Business Overview & Revenue Model

Company Description

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephro...

XORTX Therapeutics Inc Peers Comparison

Overall Rating

Financial Indicators

XRTX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-60%-40%-20%0%XRTXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
XRTX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
XRTXXortx Therapeutics1.01-2.12-67.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.